All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition
L-MIND study, MOR208 + lenalidomide in R/R DLBCL
New chemotherapy-free approaches for the treatment of lymphoid malignancies
At the 15th International Conference on Malignant Lymphoma, the Lymphoma Hub Satellite Symposium highlighted recent advances in chemotherapy-free options in the field of...
Gilles Salles | ASH 2018 | MOR208 combined with lenalidomide in patients with R/R DLBCL
Gilles Salles discusses MOR208 combined with lenalidomide in patients with R/R DLBCL at ASH 2018
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox